Biotechnology firm Biocon has announced the launch of its new product, Liraglutide, aimed at managing diabetes and obesity in the UK. This pivotal move was made public on Friday.
Biotechnology firm Biocon has announced the launch of its new product, Liraglutide, aimed at managing diabetes and obesity in the UK. This pivotal move was made public on Friday.
Administrator
Atul Chaturvedi boasts over 25 years of experience in the media industry, having held positions at esteemed organizations such as Republic TV, Times Network's Mirror Now News Channel, Times of India, Bangalore Mirror, Rajasthan Patrika Hindi newspaper, and Sakal newspaper.